COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,790 Articles (22,523 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 1080: Articles 10791-10800  | Next

Tunneling nanotubes provide a novel route for SARS-CoV-2 spreading between permissive cells and to non-permissive neuronal cells.
Pepe, A., Pietropaoli, S., Vos, M., Barba-Spaeth, G., Zurzolo, C.
10.1101/2021.11.15.468633 — Posted: 2021-11-17
Impact of SARS-CoV-2 Vaccines on Covid-19 Incidence and Mortality in the United States
Fang, F., Clemens, J. D., Zhang, Z.-F., Brewer, T. F.
10.1101/2021.11.16.21266360 — Posted: 2021-11-17
Estimating COVID-19-induced Excess Mortality in Lombardy
Maruotti, A., Jona-Lasinio, G., Divino, F., Lovison, G., Ciccozzi, M., Farcomeni, A.
10.1101/2021.11.17.21266455 — Posted: 2021-11-17
COVID-19 first and delta waves in relation to ACEI, ARB, Influenza vaccination, and comorbidity in a North Metropolitan Barcelona Health Consortium
Juanes-Gonzalez, M., Calderon-Valdiviezo, A., Losa-Puig, H., Valls-Foix, R., Gonzalez-Salvador, M., Leon-Perez, M., Pueyo Anton, L., Lozano-Paz, C., Franco-Romero, M., Vidal-Alaball, J., Puigdellivol, A.
10.1101/2021.11.17.21265440 — Posted: 2021-11-17
A booster dose of an inactivated vaccine increases neutralizing antibodies and T cell responses against SARS-CoV-2
Schultz, B. M., Melo-Gonzalez, F., Duarte, L. F., Galvez, N. M., Pacheco, G. A., Soto, J. A., Berrios, R. V., Gonzalez, L. A., Moreno-Tapia, D., Rivera-Perez, D., Hoppe-Elsholz, G., Iturriaga, C., Vallejos, O. P., Urzua, M., Vazquez, Y., Navarrete, M. S., Rojas, A., Grifoni, A., Sette, A., Weiskopf, D., Zeng, G., Meng, W., CoronaVac03CL Study Group, , Gonzalez-Aramundiz, J. V., Gonzalez, P. A., Abarca, K., Kalergis, A. M., Bueno, S. M.
10.1101/2021.11.16.21266350 — Posted: 2021-11-17
Unraveling the spatiotemporal spread of COVID-19 in Brazil through spatial network connectivity
Barrozo, L. V., Small, C.
10.1101/2021.11.16.21266414 — Posted: 2021-11-17
Attenuation of antibody titres during 3-6 months after the second dose of the BNT162b2 vaccine depends on sex, with age and smoking as risk factors for lower antibody titres at 6 months
Nomura, Y., Sawahata, M., Nakamura, Y., Koike, R., Katsube, O., Hagiwara, K., Niho, S., Masuda, N., Tanaka, T., Sugiyama, K.
10.1101/2021.11.14.21266334 — Posted: 2021-11-17 Discussion: Onsite
From online data collection to identification of disease mechanisms: The IL-1beta, IL-6 and TNF-alpha; cytokine triad is associated with post-acute sequelae of COVID-19 in a digital research cohort
Schultheiss, C., Willscher, E., Paschold, L., Gottschick, C., Klee, B., Henkes, S.-S., Bosurgi, L., Dutzmann, J., Sedding, D., Frese, T., Girndt, M., Hoell, J. I., Gekle, M., Mikolajczyk, R., Binder, M.
10.1101/2021.11.16.21266391 — Posted: 2021-11-16
COVID-19 in the Republic of Belarus: pandemic features and the interim safety and efficacy assessment of the Gam-COVID-Vac vaccine
Dashkevich, A. M., Vysotskaya, V. S., Hlinskaya, I. N., Skuranovich, A. L., Tarasenka, A. A., Karaban, I. A., Kolomiets, N. D.
10.1101/2021.11.15.21265526 — Posted: 2021-11-16
COVID-19 in Elderly Patients with Acute Kidney Injury
AYAR, Y., Deniz, O., Doner, B., Kilic, I., Demir, C., Sahin, A.
10.1101/2021.11.16.21266324 — Posted: 2021-11-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).